Literature DB >> 33763607

Significant lifespan difference between primary open-angle glaucoma and pseudoexfoliation glaucoma.

Jon Klokk Slettedal1,2, Leiv Sandvik3, Amund Ringvold1,2.   

Abstract

PURPOSE: Open-angle glaucoma (OAG) is a collective term for various subgroups of glaucoma of which primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma (PEG) are the most common. There is increasing evidence that both conditions have systemic ramifications. We wanted to examine to what extent lifespan and cause of death are influenced by POAG, pseudoexfoliation syndrome (PES), and PEG.
MATERIALS AND METHODS: Of 1864 people who underwent an eye examination in 1985-86, the presence of PES and/or glaucoma, along with date and cause of death were recorded. Based on information from the National Death Registry, the individuals were classified into the following groups of systemic diseases regarded as causing death: Cardiovascular disease (with two subgroups), cerebrovascular disease and neoplasms.
RESULTS: All 1864 persons were followed to death, up to 30 years after examination. No difference in lifespan was observed when comparing OAG (i.e. POAG and PEG together) with the rest of the population. When adjusting for gender and age at inclusion, patients with POAG showed a reduced lifespan in the cardiovascular death group (2.44 years, p = 0.043). When comparing lifespan in the neoplastic group in the glaucoma patients, POAG and PEG, directly against each other, a mean age difference of 6.87 years (p = 0.017) was found.
CONCLUSIONS: POAG patients showed reduced lifespan due to neoplasia and cardiovascular disease. Persons with PES and PEG did not show these lifespan reductions. Our main conclusion is that POAG and PEG, the two main OAG subgroups, are very different disease entities both from an ocular and a systemic point of view.
© 2021 The Authors.

Entities:  

Keywords:  Lifespan; Primary open-angle glaucoma; Pseudoexfoliation glaucoma; Pseudoexfoliation syndrome; Systemic diseases

Year:  2021        PMID: 33763607      PMCID: PMC7973303          DOI: 10.1016/j.heliyon.2021.e06421

Source DB:  PubMed          Journal:  Heliyon        ISSN: 2405-8440


  30 in total

1.  Pseudo-exfoliation and mortality.

Authors:  A Ringvold; S Blika; L Sandvik
Journal:  Acta Ophthalmol Scand       Date:  1997-06

2.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

3.  Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.

Authors:  Anne J Lee; Jie Jin Wang; Annette Kifley; Paul Mitchell
Journal:  Ophthalmology       Date:  2006-07       Impact factor: 12.079

Review 4.  A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma.

Authors:  Mona Pache; Josef Flammer
Journal:  Surv Ophthalmol       Date:  2006 May-Jun       Impact factor: 6.048

5.  Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study.

Authors:  U Schlötzer-Schrehardt; G O Naumann
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-08       Impact factor: 4.799

6.  Pseudoexfoliation and mortality: a population-based 30-year follow-up study.

Authors:  Rebecka Svensson; Curt Ekström
Journal:  Acta Ophthalmol       Date:  2014-03-26       Impact factor: 3.761

7.  Mortality in primary open-angle glaucoma and exfoliative glaucoma.

Authors:  Ahti H A Tarkkanen; Tero T Kivelä
Journal:  Eur J Ophthalmol       Date:  2014-02-18       Impact factor: 2.597

8.  The Middle-Norway eye-screening study. I. Epidemiology of the pseudo-exfoliation syndrome.

Authors:  A Ringvold; S Blika; T Elsås; J Guldahl; T Brevik; P Hesstvedt; H Johnsen; K Hoff; H Høisen; S Kjørsvik
Journal:  Acta Ophthalmol (Copenh)       Date:  1988-12

9.  Ocular pseudoexfoliation and cardiovascular disease: a national cross-section comparison study.

Authors:  Dustin D French; Curtis E Margo; Lynn E Harman
Journal:  N Am J Med Sci       Date:  2012-10

10.  Lifespan reduction due to neoplasia is nullified by pseudoexfoliation syndrome.

Authors:  Jon Klokk Slettedal; Leiv Sandvik; Amund Ringvold
Journal:  Heliyon       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.